Nevertheless, conclusions from this study suggest that kallistatin and afamin, in combination with anthropometric indicators related to overweight and obesity, may play an important role duringrecovery in MI patients, and that the levels of these two regulatory proteins may become a therapeutic target. This evidence concerns the gene AFM and Obesity.